These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20537818)

  • 1. Infectious blood or culture-grown virus: a comparison of bluetongue virus challenge models.
    Eschbaumer M; Wäckerlin R; Rudolf M; Keller M; König P; Zemke J; Hoffmann B; Beer M
    Vet Microbiol; 2010 Nov; 146(1-2):150-4. PubMed ID: 20537818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of bluetongue viraemia in sheep by real-time PCR and correlation with viral infectivity.
    Chatzinasiou E; Dovas CI; Papanastassopoulou M; Georgiadis M; Psychas V; Bouzalas I; Koumbati M; Koptopoulos G; Papadopoulos O
    J Virol Methods; 2010 Nov; 169(2):305-15. PubMed ID: 20691732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
    Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
    Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction.
    Zientara S; Bréard E; Sailleau C
    Dev Biol (Basel); 2006; 126():187-96; discussion 326-7. PubMed ID: 17058494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contamination in bluetongue virus challenge experiments.
    Eschbaumer M; Wäckerlin R; Savini G; Zientara S; Sailleau C; Bréard E; Beer M; Hoffmann B
    Vaccine; 2011 Jun; 29(26):4299-301. PubMed ID: 21557978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bluetongue virus serotype 26: infection kinetics and pathogenesis in Dorset Poll sheep.
    Batten CA; Henstock MR; Bin-Tarif A; Steedman HM; Waddington S; Edwards L; Oura CA
    Vet Microbiol; 2012 May; 157(1-2):119-24. PubMed ID: 22177889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The length of BTV-8 viraemia in cattle according to infection doses and diagnostic techniques.
    Di Gialleonardo L; Migliaccio P; Teodori L; Savini G
    Res Vet Sci; 2011 Oct; 91(2):316-20. PubMed ID: 21324498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.
    Wäckerlin R; Eschbaumer M; König P; Hoffmann B; Beer M
    Vaccine; 2010 Jun; 28(27):4348-55. PubMed ID: 20438878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental reproduction of bluetongue virus serotype 8 clinical disease in calves.
    Dal Pozzo F; De Clercq K; Guyot H; Vandemeulebroucke E; Sarradin P; Vandenbussche F; Thiry E; Saegerman C
    Vet Microbiol; 2009 May; 136(3-4):352-8. PubMed ID: 19128895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental oral infection of bluetongue virus serotype 8 in type I interferon receptor-deficient mice.
    Calvo-Pinilla E; Nieto JM; Ortego J
    J Gen Virol; 2010 Nov; 91(Pt 11):2821-5. PubMed ID: 20719994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of real-time RT-PCR as a rapid molecular approach for differentiation of field and vaccine strains of bluetongue virus serotypes 2 and 9.
    Elia G; Savini G; Decaro N; Martella V; Teodori L; Casaccia C; Di Gialleonardo L; Lorusso E; Caporale V; Buonavoglia C
    Mol Cell Probes; 2008 Feb; 22(1):38-46. PubMed ID: 17693055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A duplex real-time RT-PCR for the detection of bluetongue virus in bovine semen.
    Vanbinst T; Vandenbussche F; Dernelle E; De Clercq K
    J Virol Methods; 2010 Oct; 169(1):162-8. PubMed ID: 20674609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological and pathological findings in Bluetongue virus serotype 8 infected sheep.
    Worwa G; Hilbe M; Chaignat V; Hofmann MA; Griot C; Ehrensperger F; Doherr MG; Thür B
    Vet Microbiol; 2010 Aug; 144(3-4):264-73. PubMed ID: 20153937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon α/β receptor knockout mice as a model to study bluetongue virus infection.
    Ortego J; de la Poza F; Marín-López A
    Virus Res; 2014 Mar; 182():35-42. PubMed ID: 24100234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.